Contact Us

Fill in the contact form opposite and we will get back to you shortly. Alternatively use the contact details listed below
02921 845852
wcrc@cardiff.ac.uk
Room 1TB2 31, First Floor Main Building
Institute of Cancer & Genetics, School of Medicine
Cardiff University, University Hospital of Wales
Heath Park, Cardiff, CF14 4XN

Translational Research Committee Expertise

The people listed below form the TReC Committee, and will provide informal advice and guidance to assist with working up a submission, ready to present to a panel.

 

Dr. Matt Smalley (Scientific Chair)

Area of expertise: Breast Cancer Biology

Specifically: Mouse models of breast cancer; cancer stem cells; flow sorting.

 

Prof. John Chester (Clinical Chair)

Area of expertise: Bladder cancer, germ cell tumours and head/neck cancers.

Specifically: Trials for bladder and head/neck cancers, and in stratified medicine

 

Prof. Malcolm Mason

Area of expertise: Urological cancer

Specifically: Phase III Trials, Translational research.

 

Prof. Oliver Ottmann

Area of expertise: Haematology

Specifically: Early phase clinical trials, small molecule therapeutics, biologicals, clinical translational science, drug development.

 

Prof. Peter Barrett-Lee

Area of expertise: Breast Cancer Biology / Breast Cancer Treatments

Specifically: Consultant and Professor of Breast Cancer Studies

 

Prof. Chris Pepper

Area of expertise: Lymphoid haematological malignancies (e.g. CLL Myeloma)

Specifically: Drug Development, rational drug combination design/validation, drug resistance mechanisms.

 

Prof. Angela Casini

Area of expertise: Medicinal and Bioinorganic Chemistry

Specifically: Synthetic chemistry, design of enzyme inhibitors, development of ex vivo methods for drug screening, target identification studies on anticancer compounds, toxicity screenings.

 

Dr. Andrew Westwell

Area of expertise: Medicinal Chemistry / Pre Clinical Drug Discovery

Specifically: Synthetic medicinal chemistry

 

Dr. Rob Jones

Area of expertise: Phase 1 trials

Specifically: Early Phase protocol development, DNA checkpoint inhibitors.

 

Dr. Steve Knapper

Area of expertise: Myeloid haematological malignancies, Molecularly targeted therapies, TKIs

Specifically: Interface between pre-clinical characterisation of new agents and early phase studies. "Back to bench" testing.

 

Dr. John Staffurth

Area of expertise: Radiotherapy, prostate cancer, bladder cancer, immunology

Specifically: All aspects of technical radiotherapy, molecular radiotherapy, functional imaging, translational immunology, late phase trial design.

 

Dr. Julia Gee

Area of expertise :Endocrine resistance in breast cancer, clinical trial sample profiling during drug treatment.

Specifically: Immunohistochemistry; development and use of in vitro models; gene microarray studies.

 

Dr Andy Godkin

Area of expertise: Immunology, hepatology, gastroenterology.

Specifically: Laboratory research and translational medicine.

 

Kay Wilson

Area of expertise: Early phase research delivery.

Specifically: Research nursing, chemotherapy nursing.

 

Dr Laura Newell

Area of expertise: Technology Transfer

Specifically: Intellectual property; translational funding; research commercialisation.